The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for ...

Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25. Cleerly, the leader in ...

CT scan-assessed high right ventricle-left ventricle ratio of the heart predicts major adverse cardiovascular events in PH ...

People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...

Advances in healthcare that could assist Bermuda — including the use of artificial intelligence — will be covered in a talk ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of ...

HPV, a virus already known for causing several cancers, is now being linked to a significantly increased risk of heart ...

Health Canada has approved Riverain's ClearRead CT CAC for opportunistic coronary artery calcification (CAC) quantification on ungated chest CT exams. MIAMISBURG, OH, UNITED STATES, March 18 ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced additional investments in the company of approximately $98 million through the sale and issuance of ...

The study recruited 287 adults with HIV, on antiretroviral treatment for at least three years, and 299 age- and sex-matched HIV-negative controls to undergo screening for coronary artery disease. All ...